(Q36895375)

16 August 2017

1 reference

title

Should prophylactic surgery be used in women with a high risk of breast cancer? (English)

1 reference

16 August 2017

Klijn JG

1

1 reference

16 August 2017

Janin N

series ordinal

2

1 reference

16 August 2017

Cortés-Funes H

series ordinal

3

1 reference

16 August 2017

Colomer R

series ordinal

4

1 reference

16 August 2017

1 November 1997

1 reference

European Journal of Cancer

16 August 2017

1 reference

16 August 2017

33

1 reference

16 August 2017

2149-2159

1 reference

16 August 2017

13

1 reference

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Inheritance of proliferative breast disease in breast cancer kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

1 reference

7 January 2021

Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Mammography adherence and psychological distress among women at risk for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Cancers detected and induced in mammographic screening: new screening schedules and younger women with family history

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: The dutch experience on 24 families under surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Quantitating familial cancer risk: a resource for clinical oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Inherited breast and ovarian cancer. What are the risks? What are the choices?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Restating the risks of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Primary breast cancer after prophylactic mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Rapid detection of BRCA1 mutations by the protein truncation test

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Attitudes about genetic testing for breast-ovarian cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Attitudes towards cancer predictive testing and transmission of information to the family

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

The woman at increased risk for breast cancer: evaluation and management strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Familial breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

Changes in breast cancer incidence among Norwegian women under 50

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900360-2

7 January 2021

10.1016/S0959-8049(97)00360-2

Identifiers

DOI

1 reference

16 August 2017

1 reference